BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 9578705)

  • 1. [Prognostic markers in the histopathological diagnosis of tumors of the choroid plexus].
    Varga Z; Vajtai I
    Orv Hetil; 1998 Mar; 139(13):761-5. PubMed ID: 9578705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MIB-1 immunoreactivity reveals different labelling in low-grade and in malignant epithelial neoplasms of the choroid plexus.
    Vajtai I; Varga Z; Aguzzi A
    Histopathology; 1996 Aug; 29(2):147-51. PubMed ID: 8872148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The standard isoform of CD44 is preferentially expressed in atypical papillomas and carcinomas of the choroid plexus.
    Varga Z; Vajtai I; Aguzzi A
    Pathol Res Pract; 1996 Dec; 192(12):1225-31. PubMed ID: 9182293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumors of the choroid plexus.
    Rickert CH; Paulus W
    Microsc Res Tech; 2001 Jan; 52(1):104-11. PubMed ID: 11135453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokeratin 7 and 20 expression in choroid plexus tumors: utility in differentiating these neoplasms from metastatic carcinomas.
    Gyure KA; Morrison AL
    Mod Pathol; 2000 Jun; 13(6):638-43. PubMed ID: 10874668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant progression in choroid plexus papillomas.
    Jeibmann A; Wrede B; Peters O; Wolff JE; Paulus W; Hasselblatt M
    J Neurosurg; 2007 Sep; 107(3 Suppl):199-202. PubMed ID: 17918524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinicopathological study on choroid plexus tumors: immunohistochemical features and argyrophilic nucleolar organizer regions values].
    Shirakawa N; Kannuki S; Matsumoto K
    Noshuyo Byori; 1994; 11(1):99-105. PubMed ID: 8162158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and immunohistochemical study of 20 choroid plexus tumors: their histological diversity and the expression of markers useful for differentiation from metastatic cancer.
    Ikota H; Tanaka Y; Yokoo H; Nakazato Y
    Brain Tumor Pathol; 2011 Jul; 28(3):215-21. PubMed ID: 21394517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MIB-1 labeling index in astrocytic tumors--a clinicopathologic study.
    Neder L; Colli BO; Machado HR; Carlotti CG; Santos AC; Chimelli L
    Clin Neuropathol; 2004; 23(6):262-70. PubMed ID: 15584210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choroid plexus tumors differ from metastatic carcinomas by expression of the excitatory amino acid transporter-1.
    Beschorner R; Schittenhelm J; Schimmel H; Iglesias-Rozas JR; Herberts T; Schlaszus H; Meyermann R; Wehrmann M
    Hum Pathol; 2006 Jul; 37(7):854-60. PubMed ID: 16784985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthyretin immunoreactivity in choroid plexus neoplasms and brain metastases.
    Albrecht S; Rouah E; Becker LE; Bruner J
    Mod Pathol; 1991 Sep; 4(5):610-4. PubMed ID: 1758873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of prognostic markers in brain tumors.
    Grzybicki DM; Moore SA
    Clin Lab Med; 1999 Dec; 19(4):833-47. PubMed ID: 10572718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological study of choroid plexus tumors: immunohistochemical features and evaluation of proliferative potential by PCNA and Ki-67 immunostaining.
    Kato T; Fujita M; Sawamura Y; Tada M; Abe H; Nagashima K; Nakamura N
    Noshuyo Byori; 1996 Nov; 13(2):99-105. PubMed ID: 8958514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between histological grade and MIB-1 and p53 immunoreactivity in meningiomas.
    Ozen O; Demirhan B; Altinörs N
    Clin Neuropathol; 2005; 24(5):219-24. PubMed ID: 16167545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of choroid plexus tumors by advanced magnetic resonance spectroscopy.
    Krieger MD; Panigrahy A; McComb JG; Nelson MD; Liu X; Gonzalez-Gomez I; Gilles F; Bluml S
    Neurosurg Focus; 2005 Jun; 18(6A):E4. PubMed ID: 16048290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of p27KIP1 in human gliomas: relationship between tumor grade, proliferation index, and patient survival.
    Zagzag D; Blanco C; Friedlander DR; Miller DC; Newcomb EW
    Hum Pathol; 2003 Jan; 34(1):48-53. PubMed ID: 12605366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. P53 expression in choroid plexus neoplasms: an immunohistochemical study.
    Jay V; Ho M; Chan F; Malkin D
    Arch Pathol Lab Med; 1996 Nov; 120(11):1061-5. PubMed ID: 12049110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic study of forty-four histologically pure supratentorial oligodendrogliomas.
    Prayson RA; Mohan DS; Song P; Suh JH
    Ann Diagn Pathol; 2000 Aug; 4(4):218-27. PubMed ID: 10982299
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of EAAT-1 distinguishes choroid plexus tumors from normal and reactive choroid plexus epithelium.
    Beschorner R; Pantazis G; Jeibmann A; Boy J; Meyermann R; Mittelbronn M; Schittenhelm J
    Acta Neuropathol; 2009 Jun; 117(6):667-75. PubMed ID: 19283393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.